Enteral omega-3 in acute respiratory distress syndrome

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 2, 2009, Pages 123-128

  Singer, Pierre ^a,b   Shapiro, Haim ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute respiratory distress syndrome; Enteral nutrition; Omega 3 polyunsaturated fatty acids

Indexed keywords

ARGININE; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE LUNG INJURY; ANTIOXIDANT ACTIVITY; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CLINICAL TRIAL; DIET THERAPY; ENTERIC FEEDING; HUMAN; INTENSIVE CARE UNIT; LUNG HEMODYNAMICS; MORTALITY; OXYGEN SATURATION; OXYGENATION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; RESPIRATORY DISTRESS; REVIEW;

ACUTE LUNG INJURY; ANTIOXIDANTS; ARGININE; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; INFLAMMATION; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 61949178284     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328322e70f     Document Type: Review

References (30)

1. Leaver SK, Evans TW. Acute respiratory distress syndrome. BMJ 2007; 335:389-394.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
3. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369:1553-1564. An important overview of the diagnosis and management of ARDS.
4. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288:L3-L15.
5. Piantadosi CA, Schwarte DA. The acute respiratory distress syndrome. Ann Intern Med 2004; 141:460-470.
6. Oltermann MH. Nutrition support in the acutely ventilated patient. Respir Care Clin N Am 2006; 12:533-545.
7. Calder PC. Immunonutrition in surgical and critically ill patients. Br J Nutr 2007; 98 (Suppl 1):S133-S139. A succinct review for those not familiar with the concept of immunonutrition.
8. Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 2004; 44:273-282.
9. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007; 77:327-335.
10. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312:1217-1224.
11. Palombo JD, DeMichele SJ, Lydon EE, et al. Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids. Am J Clin Nutr 1996; 63:208-219.
12. Mancuso P, Whelan J, DeMichele SJ, et al. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 1997; 25:1198-1206.
13. Mancuso P, Whelan J, DeMichele SJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 1997; 25:523-532.
14. Mayer K, Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 2008; 11:121-127.
15. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27:1409-1420.
16. Galbán C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643-648.
17. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit Care Med 1998; 26:1164-1172.
18. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine. nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449.
19. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34:2325-2333.
20. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34:1033-1038; Erratum in Crit Care Med 2006;34:1861.
21. Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammationmodulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 2008; 32:596-605. A meta-analysis of pooled data from three randomized clinical trials (RCTs) concluding the enteral n-3 P GLA and antioxidants' formula reducing mortality, oxygenation and other relevant outcomes.
22. Theilla M, Singer P, Cohen J, Dekeyser F. A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically in patients with acute lung injury: a randomized, prospective, controlled study. Clin Nutr 2007; 26: 752-757.
23. Marik PE, Zaloga GP. Immunonutrition in critically in patients: a systematic review and analysis of the literature. Intensive Care Med 2008; 34:1980-1990. This meta-analysis suggests that the failure of omega-3 feeding to produce benefit in previous studies may have been due to excessive arginine supplementation. 24 Mayes T, Gottschlich MM, Kagan RJ. An evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. J Burn Care Res 2008; 29:82-88.
24. Yamanaka K, Saluja AK, Brown GE, et al. Protective effects of prostaglandin E1 on acute lung injury of caerulein-induced acute pancreatitis in rats. Am J Physiol 1997; 272 (1 Pt 1):G23-G30.
25. Abraham E, Baughman R, Fletcher E, et al. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med 1999; 27:1478-1485.
26. Putensen C, Hörmann C, Kleinsasser A, Putensen-Himmer G. Cardiopul-monary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157 (6 Pt 1):1 743-1 747.
27. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004:CD004477.
28. Nelson JL, De Michele SJ, Pacht ER, Wennberg AK. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. J Parenter Enterai Nutr 2003; 27:98-104.
29. Tasaka S, Amaya F, Hashimoto S, Ishizaka A. Roles of oxidants and redox signaling in the patnogenesis of acute respiratory distress syndrome. Antioxid Redox Signal 2008; 10:739-753.
30. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008; 24:215-222.